Answers are grounded in this paper and cite their sources.
Anti-cancer therapies over the few decades, faced with many challenges. And bacterial vaccine vectors have shown a potential to be replaced as the cutting-edge technology for such aspects. Bacterial vaccine vectors with a suitable DNA can be a potential option for cancer treatment as a carrier for tumoricidal agents or bacterially directed Enzyme Prodrug treatment. Throughout this study, it is planned to have a review of the use of bacteria as vehicles by different ways for cancer treatment, detailing the systems of function and achievements at preclinical and clinical levels.
No takes yet. Share an insight, caveat, or question.
Parnia Jabbari (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: